Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Sustained-release morphine for dyspnea in interstitial pneumonia
jRCTs041230028Active, not recruiting
- Start
- Sep 2023
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Open-label, single-arm trial of morphine in interstitial pneumonia. Primary endpoint: Treatment completion rate. Started Sep 2023; status: active, not recruiting.
02
Drugs
morphine
03
Conditions
interstitial pneumonia
Beyond the preview
Go deeper on jRCTs041230028.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on jRCTs041230028.